Prostate cancer
Hello Dr.
Du,
On April 5, my PSA test result was 14.3.
I went to the hospital for further examination, and my PSA increased to 17.
I underwent my first biopsy, which was benign.
However, my PSA rose to 18, still high.
An MRI revealed a tumor on the right side, and a second biopsy found cancer cells in 3 cores, with a Gleason score of 4+5=9, classified as T2.
A CT scan and bone scan showed no metastasis.
I usually feel a frequent urge to urinate, but my bladder capacity seems less than when I was younger.
The doctor has recommended a Da Vinci robotic surgery for removal.
I would like to know if I really need to undergo this surgery, or if options like HIFU (High-Intensity Focused Ultrasound) or active surveillance are viable alternatives.
Below are my medical records for your reference.
Thank you.
(Examinations and Tests)
25004 Surgical Pathology Level IV *4 items
25012 Immunohistochemical Stains, each *2 items
(Report Contents)
1.
Prostate, right lateral, TRUS biopsy, adenocarcinoma, Gleason score 9 (4 + 5).
Grade Group 5, involving 3/10 cores and 15%.
2.
Prostate, right medial, TRUS biopsy, benign prostate tissue.
3.
Prostate, left medial, TRUS biopsy, benign prostate tissue.
4.
Prostate, left lateral, TRUS biopsy, benign prostate tissue.
[Description]
The specimen is submitted in four separate bottles labeled as A: right lateral, B: right medial, C: left medial, and D: left lateral, respectively, fixed in formalin.
The specimen labeled as A consists of ten tissue fragments measuring up to 1.5 x 0.1 x 0.1 cm in size.
Grossly, they are tan and elastic.
The specimen labeled as B consists of eight tissue fragments measuring up to 1.8 x 0.1 x 0.1 cm in size.
Grossly, they are tan and elastic.
The specimen labeled as C consists of three tissue fragments measuring up to 1.7 x 0.1 x 0.1 cm in size.
Grossly, they are tan and elastic.
The specimen labeled as D consists of three tissue fragments measuring up to 1.5 x 0.1 x 0.1 cm in size.
Grossly, they are tan and elastic.
All for section and labeled as: Jar A: Right lateral, B: Right medial, C: Left medial, D: Left lateral.
Microscopic Examination:
1.
Histologic Type: Adenocarcinoma, acinar type.
2.
Histologic Grade:
(A) Right lateral region: Gleason score 4+5=9
(B) Right medial region: benign prostate tissue.
(C) Left medial region: benign prostate tissue.
(D) Left lateral region: benign prostate tissue.
3.
Highest Grade Group: 5
4.
Percentage of Gleason Pattern 4: 90%
5.
Percentage of Gleason Pattern 5: 10%
6.
Intraductal Carcinoma (IDC): Not identified.
7.
Tumor Quantitation:
(A) Right lateral region: 3 of 10 cores, involving 15% of needle core tissues.
(B) Right medial region: None.
(C) Left medial region: None.
(D) Left lateral region: None.
8.
Periprostatic Fat Invasion: Not identified.
9.
Seminal Vesicle/Ejaculatory Duct Invasion: Not identified.
10.
Lymphovascular Invasion: Not identified.
11.
Perineural Invasion: Not identified.
12.
Additional Pathologic Findings: None identified.
13.
Tumor Immunoprofile (section A): AMACR (+, diffusely), CK5/14 (loss of peripheral expression at tumor glands).
Cang Zhou, 50~59 year old female. Ask Date: 2021/08/13
Dr. Du Shixi reply Urology
Hello: There are many treatment options available, and the Da Vinci system is one of them.
You can check the hospital website you are considering for information on prostate cancer treatments and discuss the options with your physician.
Wishing you good health.
Reply Date: 2021/08/13
More Info
Understanding prostate cancer, particularly in the context of diagnosis, treatment options, and surgical interventions, is crucial for making informed decisions about your health. Based on the information provided, you have undergone a series of tests that have led to a diagnosis of prostate cancer with a Gleason score of 9 (4+5), indicating a high-grade tumor. This score suggests that the cancer is aggressive and may require prompt and effective treatment.
Diagnosis and Initial Findings
Your PSA levels have fluctuated, starting at 14.3, then 17, and finally 18, which are all elevated and indicative of potential prostate cancer. The initial biopsy returned benign results, but subsequent imaging and biopsies confirmed the presence of cancer in the right lateral region of the prostate. The Gleason score of 9 indicates a significant risk of progression and metastasis, which is a critical factor in deciding on treatment options.
Treatment Options
1. Surgical Intervention: The recommendation for a Da Vinci robotic-assisted prostatectomy is a common approach for high-grade prostate cancer. This minimally invasive surgery aims to remove the prostate gland and some surrounding tissue, which can potentially cure the cancer if it has not spread beyond the prostate. Given your Gleason score and the presence of cancer in multiple cores, surgery may be the most definitive treatment option.
2. Active Surveillance: This approach involves closely monitoring the cancer without immediate treatment. It is typically recommended for lower-grade cancers or for patients who are older or have significant comorbidities. Given your high Gleason score, active surveillance may not be advisable as it could allow the cancer to progress.
3. Focal Therapy (e.g., HIFU): High-Intensity Focused Ultrasound (HIFU) is a less invasive option that targets cancerous tissue while sparing surrounding healthy tissue. However, it is generally considered for localized disease and may not be suitable given your aggressive cancer profile.
4. Radiation Therapy: External beam radiation therapy or brachytherapy could be alternatives, especially if surgery poses significant risks. However, these options may not provide the same curative potential as surgical removal of the prostate.
5. Hormonal Therapy: If there is a concern about the cancer spreading or if surgery is not an option, androgen deprivation therapy (ADT) may be recommended. This treatment reduces testosterone levels, which can fuel prostate cancer growth.
Considerations for Surgery
Before proceeding with surgery, several factors should be evaluated:
- Overall Health: Your general health, including any comorbid conditions, will influence the surgical decision. If you have significant health issues, the risks of surgery may outweigh the benefits.
- Potential Side Effects: Surgery can lead to complications such as urinary incontinence and erectile dysfunction. It’s essential to discuss these potential outcomes with your healthcare provider.
- Consultation with Specialists: Given the complexity of your case, it may be beneficial to consult with a multidisciplinary team, including urologists, oncologists, and possibly a cardiologist if you have underlying heart conditions.
Conclusion
In summary, given your diagnosis of high-grade prostate cancer, surgical intervention is likely the most effective treatment option. While alternatives like HIFU or active surveillance exist, they may not be appropriate given the aggressiveness of your cancer. It is crucial to have an in-depth discussion with your healthcare team to weigh the risks and benefits of surgery versus other treatment modalities. Your health and quality of life should be the primary focus in making this decision.
Similar Q&A
Understanding Prostate Cancer Treatment Options and Their Effects
Hello Dr. Liu: For prostate cancer, after a comprehensive examination at the hospital, it was found to be located only in the urethra. The treatment options include: 1. Surgery 2. Chemotherapy 3. Medication. Which of these methods is the best? What are the effects on the body and...
Dr. Liu Jianting reply Urology
Is it true? Can the pathology report confirm cancer? The management approach should be determined based on factors such as age, overall health, the size and location of the cancer, and whether it has invaded other tissues or metastasized. Therefore, it is recommended that you dis...[Read More] Understanding Prostate Cancer Treatment Options and Their Effects
Choosing the Best Treatment Options for Prostate Cancer in Seniors
Regarding prostate cancer treatment options for my father, who is 70 years old with no cardiovascular disease or diabetes, he underwent a biopsy in July 2010, which resulted in T2bN0M0 and a Gleason score of 7. We hope to minimize the risks of postoperative urinary incontinence, ...
Dr. Chen Junyi reply Oncology
The CyberKnife may be a better option.[Read More] Choosing the Best Treatment Options for Prostate Cancer in Seniors
Understanding Prostate Cancer: Managing Urinary Issues and Hormone Therapy Options
Hello Doctor, my father had a PSA level of 32.5 and a prostate volume of 45 in September. He underwent a laser enucleation procedure, and the biopsy results confirmed prostate cancer. The doctor arranged for a bone scan and MRI, which showed no bone metastasis or involvement of o...
Dr. Li Minghui reply Urology
Hello: 1) Postoperative urinary incontinence generally improves gradually over several months. If the amount of leakage decreases, it will continue to improve. Medication can also help, but the extent of recovery may vary. 2) Hormonal therapy is a common treatment option that sup...[Read More] Understanding Prostate Cancer: Managing Urinary Issues and Hormone Therapy Options
Understanding Elevated PSA Levels and Prostate Cancer Treatment Options
Hello Doctor: My father is 70 years old. At the end of last year, he was referred to a major hospital due to elevated PSA levels and urinary difficulties detected at a clinic. The physician recommended laser surgery to treat benign prostatic hyperplasia (BPH) and also performed c...
Dr. Jian Weihong reply Urology
Hello: 1. The PSA level has been elevated for over two months following surgery. Although surgery and inflammation can cause an increase, it should ideally decrease. If inflammation is present, it should be well-controlled. Additionally, what is the current assessment of the tu...[Read More] Understanding Elevated PSA Levels and Prostate Cancer Treatment Options
Related FAQ
(Urology)
Prostate Cancer(Urology)
Tumor(Urology)
Bph(Urology)
Prostate Cancer(Oncology)
Prostatitis(Urology)
Hematospermia(Urology)
Nocturia(Urology)
Benign Prostatic Hyperplasia(Urology)
Viagra(Urology)